• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1996 - 2004年芬兰艰难梭菌感染相关的住院治疗和死亡情况

Hospitalizations and deaths associated with Clostridium difficile infection, Finland, 1996-2004.

作者信息

Lyytikäinen Outi, Turunen Heli, Sund Reijo, Rasinperä Marja, Könönen Eija, Ruutu Petri, Keskimäki Ilmo

机构信息

National Public Health Institute, Helsinki, Finland.

出版信息

Emerg Infect Dis. 2009 May;15(5):761-5. doi: 10.3201/eid1505.081154.

DOI:10.3201/eid1505.081154
PMID:19402963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2687028/
Abstract

To determine whether the rate of Clostridium difficile-associated disease (CDAD) and CDAD-related deaths were increasing in Finland, we analyzed registry data from 1996 through 2004. We determined the number of hospital discharges that had a diagnosis code specific for CDAD from the International Classification of Diseases, 10th revision: "enterocolitis due to Clostridium difficile" (A04.7) and "pseudomembranous enterocolitis associated with antimicrobial therapy" (K52.8), listed as any diagnosis in the National Hospital Discharge Registry. CDAD-related deaths were identified from death certificates. Those discharged with a CDAD diagnosis doubled from 810 (16/100,000 population) in 1996 to 1,787 (34/100,000) in 2004. The increase was most prominent for patients 7gt;64 years of age but concerned only those discharged with diagnosis code A04.7. The number of those discharged with diagnosis code K52.8 remained stable. The age-standardized mortality rate associated with CDAD increased from 9/million in 1998 to 17/million in 2004; the increase was limited to persons 7gt;64 years of age.

摘要

为了确定艰难梭菌相关性疾病(CDAD)的发病率及CDAD相关死亡人数在芬兰是否呈上升趋势,我们分析了1996年至2004年的登记数据。我们从国际疾病分类第10版中确定了具有CDAD特定诊断代码的医院出院人数:“艰难梭菌引起的小肠结肠炎”(A04.7)和“与抗菌治疗相关的假膜性小肠结肠炎”(K52.8),这些被列为国家医院出院登记处的任何诊断。CDAD相关死亡人数从死亡证明中确定。有CDAD诊断的出院人数从1996年的810人(每10万人中有16人)增加了一倍,至2004年的1787人(每10万人中有34人)。这种增加在64岁以上的患者中最为显著,但仅涉及那些出院诊断代码为A04.7的患者。出院诊断代码为K52.8的人数保持稳定。与CDAD相关的年龄标准化死亡率从1998年的每百万9人增加到2004年的每百万17人;这种增加仅限于64岁以上的人群。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f645/2687028/0db803b5a23e/08-1154-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f645/2687028/0c6eca488c89/08-1154-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f645/2687028/0cc27e5c3350/08-1154-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f645/2687028/0db803b5a23e/08-1154-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f645/2687028/0c6eca488c89/08-1154-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f645/2687028/0cc27e5c3350/08-1154-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f645/2687028/0db803b5a23e/08-1154-F3.jpg

相似文献

1
Hospitalizations and deaths associated with Clostridium difficile infection, Finland, 1996-2004.1996 - 2004年芬兰艰难梭菌感染相关的住院治疗和死亡情况
Emerg Infect Dis. 2009 May;15(5):761-5. doi: 10.3201/eid1505.081154.
2
Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005.2000 - 2005年美国成人艰难梭菌相关住院率及病死率上升情况
Emerg Infect Dis. 2008 Jun;14(6):929-31. doi: 10.3201/eid1406.071447.
3
Incidence and outcomes of Clostridium difficile-associated disease in hematopoietic cell transplant recipients.造血细胞移植受者艰难梭菌相关疾病的发病率及转归
Int J Hematol. 2014 Jun;99(6):758-65. doi: 10.1007/s12185-014-1577-z. Epub 2014 Apr 9.
4
Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003.1996 - 2003年美国短期住院医院出院患者的艰难梭菌感染情况
Emerg Infect Dis. 2006 Mar;12(3):409-15. doi: 10.3201/eid1205.051064.
5
The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences.马萨诸塞州医院艰难梭菌相关疾病新出现的感染挑战:临床和经济后果
Infect Control Hosp Epidemiol. 2007 Nov;28(11):1219-27. doi: 10.1086/522676. Epub 2007 Oct 3.
6
Increase in Clostridium difficile-related hospitalizations among infants in the United States, 2000-2005.2000 - 2005年美国婴儿中艰难梭菌相关住院病例的增加情况。
Pediatr Infect Dis J. 2008 Dec;27(12):1111-3. doi: 10.1097/inf.0b013e31817eef13.
7
Rates of Clostridium difficile infection in patients discharged from Spanish hospitals, 1997-2005.1997年至2005年西班牙医院出院患者艰难梭菌感染率
Infect Control Hosp Epidemiol. 2008 Sep;29(9):887-9. doi: 10.1086/590392.
8
Clostridium difficile hospitalizations in Louisiana: a 10 year review.路易斯安那州艰难梭菌住院情况:十年回顾
J La State Med Soc. 2011 Jul-Aug;163(4):192-5.
9
Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population.艰难梭菌感染及其在儿科炎症性肠病患者中的治疗。
J Pediatr Gastroenterol Nutr. 2011 Apr;52(4):437-41. doi: 10.1097/MPG.0b013e3181f97209.
10
Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease.炎症性肠病患者中艰难梭菌相关性腹泻的健康负担增加。
Aliment Pharmacol Ther. 2011 Jun;33(12):1322-31. doi: 10.1111/j.1365-2036.2011.04661.x. Epub 2011 Apr 24.

引用本文的文献

1
Current and Ongoing Developments in Targeting Infection and Recurrence.针对感染和复发的当前及正在进行的进展。
Microorganisms. 2024 Jun 15;12(6):1206. doi: 10.3390/microorganisms12061206.
2
Economic burden and cost-effectiveness of therapies for infection: a narrative review.感染治疗的经济负担和成本效益:一项叙述性综述
Therap Adv Gastroenterol. 2021 May 30;14:17562848211018654. doi: 10.1177/17562848211018654. eCollection 2021.
3
Estimation of Risk of Death Attributable to Acute Gastroenteritis Not Caused by Infection Among Hospitalized Adults in England.

本文引用的文献

1
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008.2008年欧洲艰难梭菌PCR核糖体分型027感染的最新情况
Euro Surveill. 2008 Jul 31;13(31):18942.
2
Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005.2000 - 2005年美国成人艰难梭菌相关住院率及病死率上升情况
Emerg Infect Dis. 2008 Jun;14(6):929-31. doi: 10.3201/eid1406.071447.
3
Healthcare-associated infections in Finnish acute care hospitals: a national prevalence survey, 2005.2005年芬兰急症医院的医疗保健相关感染:一项全国患病率调查
英格兰住院成人中由非感染性急性胃肠炎导致的死亡风险估计
Clin Epidemiol. 2021 Apr 23;13:309-315. doi: 10.2147/CLEP.S296516. eCollection 2021.
4
Global burden of infections: a systematic review and meta-analysis.全球 感染负担:系统评价和荟萃分析。
J Glob Health. 2019 Jun;9(1):010407. doi: 10.7189/jogh.09.010407.
5
Prevalence of Clostridium Difficile-Associated Diarrhoea in Hospitalised Patients (Results of a Russian Prospective Multicentre Study).住院患者艰难梭菌相关性腹泻的患病率(一项俄罗斯前瞻性多中心研究的结果)
Infect Dis Ther. 2018 Dec;7(4):523-534. doi: 10.1007/s40121-018-0209-y. Epub 2018 Sep 10.
6
Hospital-acquired Clostridium difficile infection in Mainland China: A seven-year (2009-2016) retrospective study in a large university hospital.中国大陆获得性艰难梭菌感染:一家大型大学医院的七年(2009-2016 年)回顾性研究。
Sci Rep. 2017 Aug 29;7(1):9645. doi: 10.1038/s41598-017-09961-0.
7
Risk factors for infections - an overview of the evidence base and challenges in data synthesis.感染的危险因素——证据基础概述及数据综合的挑战。
J Glob Health. 2017 Jun;7(1):010417. doi: 10.7189/jogh.07.010417.
8
Adherence to clinical practice guidelines for the management of Clostridium difficile infection in Japan: a multicenter retrospective study.日本艰难梭菌感染管理临床实践指南的依从性:一项多中心回顾性研究。
Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1947-1953. doi: 10.1007/s10096-017-3018-4. Epub 2017 Jun 2.
9
Clostridium difficile infections in Finland, 2008-2015: trends, diagnostics and ribotypes.芬兰艰难梭菌感染:2008-2015 年的趋势、诊断和核糖体分型。
Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1939-1945. doi: 10.1007/s10096-017-3017-5. Epub 2017 May 30.
10
Infection prevention and control of a global review of guidelines, strategies, and recommendations.全球指南、策略及建议综述中的感染预防与控制
J Glob Health. 2016 Dec;6(2):020410. doi: 10.7189/jogh.06.020410.
J Hosp Infect. 2008 Jul;69(3):288-94. doi: 10.1016/j.jhin.2008.03.005. Epub 2008 Apr 25.
4
Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study.艰难梭菌PCR核糖体分型027的临床严重程度:一项病例对照研究。
PLoS One. 2008 Mar 19;3(3):e1812. doi: 10.1371/journal.pone.0001812.
5
Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.1999 - 2004年美国艰难梭菌相关死亡率的上升
Emerg Infect Dis. 2007 Sep;13(9):1417-9. doi: 10.3201/eid1309.061116.
6
First isolation of Clostridium difficile PCR ribotype 027 in Finland.艰难梭菌PCR核糖型027在芬兰的首次分离。
Euro Surveill. 2007 Nov 8;12(11):E071108.2. doi: 10.2807/esw.12.45.03303-en.
7
The validation of the Finnish Hospital Discharge Register and Causes of Death Register data on stroke diagnoses.芬兰医院出院登记册及死因登记册中中风诊断数据的验证。
Eur J Cardiovasc Prev Rehabil. 2007 Jun;14(3):380-5. doi: 10.1097/01.hjr.0000239466.26132.f2.
8
Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004.艰难梭菌相关感染的临床特征及菌株的分子特征:一项2000 - 2004年回顾性研究的结果
Infect Control Hosp Epidemiol. 2007 Feb;28(2):131-9. doi: 10.1086/511794. Epub 2007 Jan 24.
9
ICD-9 codes and surveillance for Clostridium difficile-associated disease.用于艰难梭菌相关疾病的国际疾病分类第九版编码及监测
Emerg Infect Dis. 2006 Oct;12(10):1576-9. doi: 10.3201/eid1210.060016.
10
A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec.艰难梭菌北美脉冲场型1菌株的地理传播情况以及魁北克艰难梭菌相关疾病的流行病学情况概述。
Clin Infect Dis. 2007 Jan 15;44(2):238-44. doi: 10.1086/510391. Epub 2006 Dec 6.